Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2020 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
SLDB on Nasdaq
Shares outstanding
77,533,333
Price per share
$5.62
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
81,352,218
Total reported value
$458,837,087
% of total 13F portfolios
0%
Share change
+16,211
Value change
-$1,203,896
Number of holders
123
Price from insider filings
$5.62
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 16% $43,800,272 11,934,679 Perceptive Advisors LLC 19 Feb 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $43,346,504 7,997,510 RA Capital Management, L.P. 12 Aug 2025
Invus Global Management, LLC 9.6% +2.2% $27,216,371 +$13,457,391 7,415,905 +98% Raymond Debbane 31 Mar 2025
Vestal Point Capital, LP 7.5% +260% $32,796,600 +$22,906,533 5,815,000 +232% Vestal Point Capital, LP 31 Dec 2025
BlackRock, Inc. 6.1% $22,954,472 4,712,573 BlackRock, Inc. 30 Jun 2025
Adage Capital Management, L.P. 1.8% -67% $7,896,000 -$14,664,000 1,400,000 -65% Adage Capital Management, L.P. 31 Dec 2025

As of 31 Dec 2025, 123 institutional investors reported holding 81,352,218 shares of Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB). This represents 105% of the company’s total 77,533,333 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB) together control 95% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PERCEPTIVE ADVISORS LLC 15% 11,833,539 0% 1.2% $66,741,160
Bain Capital Life Sciences Investors, LLC 10% 7,911,669 0% 3.4% $44,621,813
Siren, L.L.C. 9.9% 7,690,405 +3.7% 1.3% $43,373,884
Vestal Point Capital, LP 7.5% 5,815,000 +95% 1.2% $32,796,600
RA CAPITAL MANAGEMENT, L.P. 7.5% 5,811,423 0% 0.34% $32,776,426
BlackRock, Inc. 6.3% 4,869,682 +3.1% 0% $27,465,007
VANGUARD GROUP INC 4.5% 3,454,959 +12% 0% $19,485,969
CITADEL ADVISORS LLC 3.4% 2,663,863 +2.7% 0.01% $15,024,188
ARMISTICE CAPITAL, LLC 3.4% 2,612,000 +179% 0.36% $14,731,680
Point72 Asset Management, L.P. 3.1% 2,416,108 +81% 0.02% $13,626,849
FMR LLC 2.6% 2,029,898 -30% 0% $11,448,625
Redmile Group, LLC 2.4% 1,860,542 -2% 0.77% $10,493,457
Alyeska Investment Group, L.P. 2.2% 1,682,805 0% 0.03% $9,491,020
Nantahala Capital Management, LLC 2.1% 1,603,336 -5.6% 0.54% $9,042,815
FRANKLIN RESOURCES INC 2.1% 1,599,233 +0% 0% $9,019,674
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.8% 1,400,000 -65% 0.01% $7,896,000
Monashee Investment Management LLC 1.7% 1,349,771 4.3% $7,612,708
GEODE CAPITAL MANAGEMENT, LLC 1.6% 1,267,392 -1.5% 0% $7,149,537
STATE STREET CORP 1.4% 1,087,413 -0.54% 0% $6,133,009
GOLDMAN SACHS GROUP INC 1.3% 1,006,306 +49% 0% $5,675,566
Finepoint Capital LP 1.2% 961,251 0% 1% $5,421,456
UBS Group AG 1.2% 911,409 +26% 0% $5,140,346
Birchview Capital, LP 0.91% 705,955 +138% 2.3% $3,981,586
DIMENSIONAL FUND ADVISORS LP 0.88% 679,084 +53% 0% $3,830,140
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.64% 499,293 -0.87% 0% $2,816,013

Institutional Holders of Solid Biosciences Inc. - Common Stock, par value $0.001 per share (SLDB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 81,352,218 $458,837,087 -$1,203,896 $5.64 123
2025 Q3 81,357,999 $501,971,186 -$1,773,199 $6.17 122
2025 Q2 82,208,819 $400,360,815 +$32,116,218 $4.87 110
2025 Q1 78,846,500 $291,701,746 +$157,692,840 $3.70 121
2024 Q4 36,331,707 $145,326,212 -$2,638,776 $4.00 86
2024 Q3 35,844,916 $249,839,838 -$25,277,188 $6.97 90
2024 Q2 37,594,933 $213,228,886 +$13,669,240 $5.67 78
2024 Q1 34,987,922 $465,886,559 +$255,393,890 $13.32 52
2023 Q4 16,633,699 $102,223,957 +$4,578,230 $6.14 38
2023 Q3 16,169,847 $40,746,223 -$462,509 $2.52 34
2023 Q2 16,340,241 $85,622,446 +$3,108,792 $5.24 34
2023 Q1 15,773,407 $74,764,734 +$2,205,404 $4.74 35
2022 Q4 15,014,401 $80,763,090 +$80,763,090 $5.38 30
2020 Q4 0 $0 -$623,259 $5.62 0
2020 Q3 307,024 $623,259 +$623,259 $2.03 1